Genopole ensures access to 24 shared-use technological and ancillary services platforms for the businesses and laboratories in its own ecosystem and more largely for the Île-de-France scientific community.

Its objective is to provide these entities with concrete solutions across all biotech-associated fields of research: cellular and molecular biology, structural biology, analytical chemistry, bioproduction, and much more. Counting more than 650 pieces of shared-use equipment, including some rare high-tech devices, Genopole’s platforms are vital enablers of success not only for the academic labs contributing to new discoveries but also the biotech companies needing to confirm the potential of their innovations. Through Genopole’s SATURNE1 call for proposals, €1.1 million in new, cutting-edge, shared-use equipment was acquired in 2023 to ensure that public and private researchers are able to pursue their work in the best possible conditions. Among these new technologies are (i) a mass photometer (Refeyn TwoMP) acquired by Genopole for the LAMBE2 mass spectrometry platform, (ii) a high throughput / high content imager (Revvity Operetta CLS) for the SABNP structural biology platform, and finally (iii) a spectrophotometer (Ozyme NanoDrop One) and (iv) a real-time PCR system (Biorad CFX OPUS 96) for the company Endogene.Bio.

1 SATURNE: support via the acquisition of technologies useful for novel research and business
2 LAMBE: Analysis, Modeling, Materials for Biology and the Environment (CNRS, University of Évry, University of Cergy-Pontoise)